|
Status |
Public on Mar 13, 2023 |
Title |
Epigenetic dysregulation from chromosomal transit in micronuclei [RPE-1 CUT&RUN] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Chromosomal instability (CIN) and epigenetic reprograming are characteristic of advanced and metastatic human cancers, yet whether they are mechanistically linked is unknown. Here we show that missegregation of mitotic chromosomes, their sequestration in micronuclei, and subsequent micronuclear envelope rupture significantly disrupt normal histone post-translational modifications, a phenomenon conserved across humans and mice as well as cancer and non-transformed cells. Mislocalization of missegregating chromosomes during anaphase promotes loss of Histone H2B ubiquitination enrichment of histone H3 trimethylation, whereas micronuclear rupture engenders loss of histone H3 acetylation and histone H2A ubiquitination. Using fluorescence lifetime imaging, ATAC-see, and ATAC-seq we show that micronuclei exhibit profound differences in chromatin accessibility. Additionally, chromosomes that are reincorporated into the primary nucleus after transient encapsulation in micronuclei exhibit durable epigenetic dysregulation. Thus, in addition to genomic copy number alterations, CIN can serve as a vehicle for stochastic epigenetic reprogramming and heterogeneity in cancer.
|
|
|
Overall design |
CUR&RUN using H3K4me3, H3K27me3 and H3K27ac antibodies on RPE-1 cells p53KO or p53KO LMB2 OE, treated with either reversine or DMSO (vehicle control) long term
|
|
|
Contributor(s) |
Agustinus AS, Raviram R, Cypher E |
Citation(s) |
37286593 |
|
Submission date |
Sep 23, 2022 |
Last update date |
Jun 14, 2023 |
Contact name |
Albert S Agustinus |
Organization name |
Memorial Sloan Kettering Cancer Center
|
Street address |
408 East 69th Street, Room 419-G
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10021 |
Country |
USA |
|
|
Platforms (1) |
|
Samples (24)
|
GSM6598150 |
RPE-1 p53KO Reversine H3K4me3 biol rep 2 |
GSM6598151 |
RPE-1 p53KO LMB2OE DMSO H3K4me3 biol rep 1 |
GSM6598152 |
RPE-1 p53KO LMB2OE DMSO H3K4me3 biol rep 2 |
GSM6598153 |
RPE-1 p53KO LMB2OE Reversine H3K4me3 biol rep 1 |
GSM6598154 |
RPE-1 p53KO LMB2OE Reversine H3K4me3 biol rep 2 |
GSM6598155 |
RPE-1 p53KO DMSO H3K27me3 biol rep 1 |
GSM6598156 |
RPE-1 p53KO DMSO H3K27me3 biol rep 2 |
GSM6598157 |
RPE-1 p53KO Reversine H3K27me3 biol rep 1 |
GSM6598158 |
RPE-1 p53KO Reversine H3K27me3 biol rep 2 |
GSM6598159 |
RPE-1 p53KO LMB2OE DMSO H3K27me3 biol rep 1 |
GSM6598160 |
RPE-1 p53KO LMB2OE DMSO H3K27me3 biol rep 2 |
GSM6598161 |
RPE-1 p53KO LMB2OE Reversine H3K27me3 biol rep 1 |
GSM6598162 |
RPE-1 p53KO LMB2OE Reversine H3K27me3 biol rep 2 |
GSM6598163 |
RPE-1 p53KO DMSO H3K27ac biol rep 1 |
GSM6598164 |
RPE-1 p53KO DMSO H3K27ac biol rep 2 |
GSM6598165 |
RPE-1 p53KO Reversine H3K27ac biol rep 1 |
GSM6598166 |
RPE-1 p53KO Reversine H3K27ac biol rep 2 |
GSM6598167 |
RPE-1 p53KO LMB2OE DMSO H3K27ac biol rep 1 |
GSM6598168 |
RPE-1 p53KO LMB2OE DMSO H3K27ac biol rep 2 |
GSM6598169 |
RPE-1 p53KO LMB2OE Reversine H3K27ac biol rep 1 |
GSM6598170 |
RPE-1 p53KO LMB2OE Reversine H3K27ac biol rep 2 |
|
This SubSeries is part of SuperSeries: |
GSE186589 |
Epigenetic dysregulation from chromosomal transit in micronuclei |
|
Relations |
BioProject |
PRJNA883672 |